Answers are grounded in this paper and cite their sources.
The mutation spectrum of the ABCA4 gene in Chinese patients is quite different from that for Caucasian patients. The establishment of the mutation profile will facilitate ABCA4 screening and risk evaluation for Chinese patients with STGD1.
No takes yet. Share an insight, caveat, or question.
Jiang et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: